6-KThe Wire
YD Bio Ltd files 6-K
Filed Jan 30, 2026 · 6mo ago · Accession 0001213900-26-009916
Plain English
YD Bio Limited entered into a binding letter of intent to acquire Safe Save Medical Cell Sciences & Technology Co., Ltd. for an expected total consideration of NT$839,832,000. The transaction is subject to customary closing conditions and due diligence, with a target closing within 30 days after March 20, 2026.
Filing details
- Company
- YD Bio Ltd
- Ticker
- YDES
- CIK
- 2011674
- Form type
- 6-K
- Filing date
- Jan 30, 2026
- Report date
- Jan 30, 2026
- Document
- ea0274702-6k_ydbio.htm
- Size
- 40 KB